Want to see AU:VHL full AI Analyst Report?
VHL Stock Chart & Stats
AU$0.01
>-AU$0.01(-16.67%)
At close: 4:00 PM EDT
AU$0.01
>-AU$0.01(-16.67%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.04
Previous CloseN/A
Volume4.82M
Average Volume (3M)960.88K
Market Cap
AU$28.18M
Enterprise ValueAU$18.32M
Total Cash (Recent Filing)AU$3.08M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta1.36
Next Earnings
Mar 03, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,348,677,200
10 Day Avg. Volume869,619
30 Day Avg. Volume960,885
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.25
Price to Sales (P/S)4.71
P/FCF Ratio-2.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$11.80M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthRevenue growth accelerated sharply in the latest annual period, indicating that Vitasora Health is gaining commercial traction. If this momentum persists, a larger revenue base could improve operating leverage and provide a foundation for eventual margin recovery as the business scales.
Debt-Free Balance SheetZero total debt reduces near-term solvency and refinancing pressure, while allowing more operating flexibility than a highly leveraged structure. This balance-sheet position gives management greater scope to fund development or restructure operations without immediate creditor constraints.
Meaningful Equity CushionThe sizable equity base relative to assets provides a meaningful cushion against financial shocks and supports continued operations despite current losses. Although cash usage remains a concern, this capital structure offers more resilience and flexibility than a balance sheet dominated by debt.
Bears Say
Severe UnprofitabilityCosts exceeding revenue at the gross-profit level indicate that the current business model is not yet economically efficient. Deep losses across EBITDA, EBIT, and net income increase dependence on future growth and require substantial improvement in pricing, costs, or scale to become sustainable.
Persistent Cash BurnMaterially negative operating and free cash flow means growth is not currently self-funded and the company continues consuming capital to operate. Unless cash conversion improves, ongoing funding needs could limit strategic flexibility and increase reliance on external capital.
Potential Equity DilutionA debt-free structure does not eliminate funding risk when losses and cash burn continue. If Vitasora Health must raise equity to support operations, persistent negative returns could dilute existing holders and reduce the long-term value created by future commercial growth.
Vitasora Health News
VHL FAQ
What was Vitasora Health’s price range in the past 12 months?
Vitasora Health lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is Vitasora Health’s market cap?
Vitasora Health’s market cap is AU$28.18M.
When is Vitasora Health’s upcoming earnings report date?
Vitasora Health’s upcoming earnings report date is Mar 03, 2027 which is in 128 days.
How were Vitasora Health’s earnings last quarter?
Vitasora Health released its earnings results on Aug 28, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of -AU$0.002 by -AU$0.001.
Is Vitasora Health overvalued?
According to Wall Street analysts Vitasora Health’s price is currently Overvalued.
Does Vitasora Health pay dividends?
Vitasora Health does not currently pay dividends.
What is Vitasora Health’s EPS estimate?
Vitasora Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vitasora Health have?
Vitasora Health has 2,348,677,200 shares outstanding.
What happened to Vitasora Health’s price movement after its last earnings report?
Vitasora Health reported an EPS of -AU$0.003 in its last earnings report, missing expectations of -AU$0.002. Following the earnings report the stock price went up 7.143%.
Which hedge fund is a major shareholder of Vitasora Health?
Currently, no hedge funds are holding shares in AU:VHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vitasora Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-79.51%
Trailing 12-Months
Asset Growth
8.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Vitasora Health
Headquartered in Melbourne, Australia, Vitasora Health Limited specializes in the research, development, and market introduction of medical devices across Australia and the United States. The company's portfolio also includes the creation of mobile health applications. Notably, the firm, previously known as Respiri Limited, officially rebranded as Vitasora Health Limited in April 2025.
Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1
―
Mach7 Technologies
―
Beamtree Holdings Ltd
―
Alcidion Group Limited
―
PainChek Ltd
―